Zobrazeno 1 - 10
of 389
pro vyhledávání: ''
Publikováno v:
Leukemialymphoma. 60(14)
In classical Hodgkin lymphoma (cHL), the significance of the interplay between Hodgkin and Reed-Sternberg cells (HRS) and reactive T cells remains poorly defined. By immunohistochemistry on bioptic cHL specimens, we found that HRS and surrounding T l
Publikováno v:
Leukemialymphoma. 60(13)
Acute lymphoblastic leukemia (ALL) is a genetically complex and heterogeneous disease for which a wide range of genetic variations has been identified. With the need for comprehensive high-throughput analysis, we have designed a comprehensive next-ge
Publikováno v:
Leukemialymphoma. 60(13)
Multiple myeloma (MM) is a common hematological malignancy and remains incurable. MiRNA-335 is a classic tumor suppressor, yet its expression pattern and biological role in MM is unclear. The aim of the present study was to determine the expression p
Autor:
Liesbeth C. de Wreede, Jürgen Finke, Diderik Jan Eikema, Jorge Sierra, Yves Beguin, Gérard Socié, Achilles Anagnostopoulos, Zübeyde Nur Özkurt, Anja van Biezen, Tobias Gedde-Dahl, Guido Kobbe, Maija Itälä-Remes, Dietger Niederwieser, Linda Koster, Marie Robin, Theo de Witte, Pavel Jindra, Johan Maertens, Dimitris Ziagkos, Eline M. P. Cremers, Nicolaus Kröger, Dietrich W. Beelen, Arnon Nagler, Per Ljungman
Publikováno v:
Cremers, E M P, de Witte, T, de Wreede, L, Eikema, D-J, Koster, L, van Biezen, A, Finke, J R, Socié, G, Beelen, D, Maertens, J, Nagler, A, Kobbe, G, Ziagkos, D, Itälä-Remes, M, Gedde-Dahl, T, Sierra, J, Niederwieser, D, Ljungman, P, Beguin, Y, Ozkurt, Z N, Anagnostopoulos, A, Jindra, P, Robin, M & Kröger, N 2019, ' A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation * ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2404-2414 . https://doi.org/10.1080/10428194.2019.1594215
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. This prospective non-interventional study evalua
Publikováno v:
Leukemialymphoma. 60(5)
Chronic lymphocytic leukemia (CLL) constitutes the largest percentage of adult leukemia cases in Western countries. Classically, fludarabine (Flu) is an effective drug used as a first-line therapy for CLL; however, Flu resistance limits its clinical
Autor:
Johanna Flach, Alice Fabarius, Susanne Brendel, Christel Weiss, Wolf-Karsten Hofmann, Helga Kleiner, Wolfgang Seifarth, Torsten J. Schulze, Henning D. Popp, Sabrina Ruppenthal, Frederik Wenz, Sven Schneider
Publikováno v:
Leukemialymphoma. 60(3)
Accumulation of DNA damage and alteration of the DNA damage response (DDR) are critical features of genetic instability that is presumed to be implicated in the pathogenesis of monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (C
Autor:
Nicolas van Baren, Pascale Saussoy, Marie-Sophie Dheur, Pierre Coulie, Eric Van Den Neste, Jean-Philippe Defour, Gaëlle Tilman, Hélène Poirel, Geneviève Ameye, Alessandra Camboni
Publikováno v:
Leukemia & lymphoma, Vol. 60, no. 4, p. 1043-1052 (2019)
High-grade B-cell lymphomas with MYC and BCL2 or BCL6 rearrangements are highly aggressive B-cell lymphomas called double-hit lymphomas (HGBL-DH). They are particularly refractory to standard treatments and carry a poor prognosis. Fragments of resect
Autor:
Ewa Balcerczak, Dariusz Wołowiec, Maciej Borowiec, Tadeusz Robak, Pawel Karpinski, Ewa Lech-Marańda, Ewelina Ziolkowska, Maria M. Sasiadek, Jerzy Z. Blonski, Anna Korycka-Wołowiec
Publikováno v:
Leukemialymphoma. 60(6)
We studied whether bendamustine (BENDA) alone or with rituximab (RIT) modifies in vitro expression of apoptosis-involved genes and proteins of chronic lymphocytic leukemia (CLL) cells depending on ...
Autor:
Raija Silvennoinen, Ville Varmavuo, Jukka Pelkonen, Jaakko Valtola, Pentti Mäntymaa, Antti Ropponen, Marjaana Säily, Timo Siitonen, Esa Jantunen, Mervi Putkonen, Marja Pyörälä, Marja Sankelo, Eeva-Riitta Savolainen, Anu Partanen
Publikováno v:
Leukemialymphoma. 60(2)
The composition of autologous blood grafts after cryopreservation, post-transplant hematological recovery up to 1 year and immune recovery up to 6 months as well as outcome was analyzed in 87 patients with multiple myeloma (MM). The patients receivin
Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma
Autor:
Tricia White, Edward A. Neuwelt, Kirsten Johansson, Laszlo Szidonya, Nancy D. Doolittle, Prakash Ambady, Jessica James, Caroline Jezierski, Jenny Firkins
Publikováno v:
Leukemialymphoma. 60(2)
Primary central nervous system lymphoma (PCNSL) is an extemely rare, CD20+ non-germinal center B cell lymphoma (diffuse large cell type) in a bed of T-cell rich tumor microenvironment. The prognost...